VERASTEM ONCOLOGY
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. Its portfolio consists of small molecule kinase inhibitors that inhibit critical signaling pathways, which promote cancer cell survival and tumor growth.
VERASTEM ONCOLOGY
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2010-01-01
Address:
Needham, Massachusetts, United States
Country:
United States
Website Url:
http://www.verastem.com
Total Employee:
101+
Status:
Active
Contact:
1-781-292-4200
Email Addresses:
[email protected]
Total Funding:
220 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Verastem Oncology
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Verastem Oncology
Bessemer Venture Partners
Bessemer Venture Partners investment in Series C - Verastem Oncology
MPM Capital
MPM Capital investment in Series C - Verastem Oncology
Longwood Fund
Longwood Fund investment in Series C - Verastem Oncology
Cardinal Partners
Cardinal Partners investment in Series C - Verastem Oncology
Astellas Venture Management
Astellas Venture Management investment in Series B - Verastem Oncology
Bessemer Venture Partners
Bessemer Venture Partners investment in Series B - Verastem Oncology
MPM Capital
MPM Capital investment in Series B - Verastem Oncology
Cardinal Partners
Cardinal Partners investment in Series B - Verastem Oncology
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-22 | Verastem Oncology Appoints Louis J. Denis, M.D., as Chief Medical Officer |
Official Site Inspections
http://www.verastem.com Semrush global rank: 4.91 M Semrush visits lastest month: 1.77 K
- Host name: 136.184.190.35.bc.googleusercontent.com
- IP address: 35.190.184.136
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
